Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29987 | 144 | 30.9 | 60% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3774 | 674 | INMUNOFERON//NODULAR SCLERODERMA//PROPIONIBACTERIUM AVIDUM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LPS HYPERSENSITIVITY | Author keyword | 2 | 67% | 1% | 2 |
2 | CORYNEBACTERIUM PARVUM | Author keyword | 1 | 25% | 3% | 5 |
3 | NCPP | Author keyword | 1 | 100% | 1% | 2 |
4 | C PYRUVICIPRODUCENS | Author keyword | 1 | 50% | 1% | 1 |
5 | ERYTHROCYTE PHAGOCYTOSIS | Author keyword | 1 | 50% | 1% | 1 |
6 | HUAIAN MATERNAL CHILD HLTH HOSP | Address | 1 | 50% | 1% | 1 |
7 | HYPERSENSITIVITY TYPE I | Author keyword | 1 | 50% | 1% | 1 |
8 | PROIONIBACTERIUM ACNES | Author keyword | 1 | 50% | 1% | 1 |
9 | R3327 MATLYLU | Author keyword | 1 | 50% | 1% | 1 |
10 | RECH ROUSSEL | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LPS HYPERSENSITIVITY | 2 | 67% | 1% | 2 | Search LPS+HYPERSENSITIVITY | Search LPS+HYPERSENSITIVITY |
2 | CORYNEBACTERIUM PARVUM | 1 | 25% | 3% | 5 | Search CORYNEBACTERIUM+PARVUM | Search CORYNEBACTERIUM+PARVUM |
3 | NCPP | 1 | 100% | 1% | 2 | Search NCPP | Search NCPP |
4 | C PYRUVICIPRODUCENS | 1 | 50% | 1% | 1 | Search C+PYRUVICIPRODUCENS | Search C+PYRUVICIPRODUCENS |
5 | ERYTHROCYTE PHAGOCYTOSIS | 1 | 50% | 1% | 1 | Search ERYTHROCYTE+PHAGOCYTOSIS | Search ERYTHROCYTE+PHAGOCYTOSIS |
6 | HYPERSENSITIVITY TYPE I | 1 | 50% | 1% | 1 | Search HYPERSENSITIVITY+TYPE+I | Search HYPERSENSITIVITY+TYPE+I |
7 | PROIONIBACTERIUM ACNES | 1 | 50% | 1% | 1 | Search PROIONIBACTERIUM+ACNES | Search PROIONIBACTERIUM+ACNES |
8 | R3327 MATLYLU | 1 | 50% | 1% | 1 | Search R3327+MATLYLU | Search R3327+MATLYLU |
9 | LCMV INFECTION | 0 | 33% | 1% | 1 | Search LCMV+INFECTION | Search LCMV+INFECTION |
10 | RAT PROSTATE CANCER | 0 | 33% | 1% | 1 | Search RAT+PROSTATE+CANCER | Search RAT+PROSTATE+CANCER |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IL 18 PRODUCTION | 3 | 29% | 7% | 10 |
2 | R 3327 AT | 1 | 50% | 1% | 1 |
3 | C57BL 10SCCR MICE | 1 | 12% | 3% | 5 |
4 | C PARVUM | 0 | 20% | 1% | 2 |
5 | CLONOGENIC CELL ASSAY | 0 | 33% | 1% | 1 |
6 | ENDOTOXIC PROPERTIES | 0 | 33% | 1% | 1 |
7 | PURIFIED SOLUBLE POLYSACCHARIDE | 0 | 20% | 1% | 1 |
8 | KILLED CORYNEBACTERIUM PARVUM | 0 | 11% | 1% | 1 |
9 | SALMONELLA ABORTUS EQUI | 0 | 10% | 1% | 1 |
10 | CARRAGEENAN PRETREATMENT | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: Benefits and hazards of LPS hypersensitivity | 2008 | 53 | 53 | 30% |
BACTERIAL-ENDOTOXINS - BIOLOGICAL PROPERTIES AND MECHANISMS OF ACTION | 1993 | 11 | 13 | 31% |
Microbial-based therapy of cancer - A new twist to age old practice | 2004 | 10 | 51 | 4% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUAIAN MATERNAL CHILD HLTH HOSP | 1 | 50% | 0.7% | 1 |
2 | RECH ROUSSEL | 1 | 50% | 0.7% | 1 |
3 | UNIDADE ONCOL EXPTDISCIPLINA BIOL CELULAR | 1 | 50% | 0.7% | 1 |
4 | BIOASSAYS DRUGS | 0 | 33% | 0.7% | 1 |
5 | HEPATOL LIVER | 0 | 25% | 0.7% | 1 |
6 | POST PROGRAM IND BIOTECHNOL | 0 | 17% | 0.7% | 1 |
7 | MEDIUM | 0 | 14% | 0.7% | 1 |
8 | DISCIPLINA BIOL CELULARUNIDADE ONCOL EXPT | 0 | 100% | 0.7% | 1 |
9 | DISCIPLINA BIOL CELULARUNONEX | 0 | 100% | 0.7% | 1 |
10 | DISCIPLINA PARASITOLCINTERGEN | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189405 | NODULAR SCLERODERMA//PROPIONIBACTERIUM AVIDUM//KELOIDAL SCLERODERMA |
2 | 0.0000169588 | BIOL GENET BACTERIAL CELL WALL//FC GAMMA RIII ALPHA//HUMAN INJECTIONS |
3 | 0.0000165047 | INMUNOFERON//GLYCOPHOSPHOPEPTICAL//AM3 |
4 | 0.0000147058 | D GALACTOSAMINE//BICYCLOL//CON A INDUCED HEPATITIS |
5 | 0.0000092607 | ENDOTOXIN TOLERANCE//LPS TOLERANCE//IRAK M |
6 | 0.0000086985 | MURINE MODELS OF SLE//LI AND NZB W MICE//LI AND RENAL DISEASE |
7 | 0.0000085184 | MD 2//CD14//LIPOPOLYSACCHARIDE BINDING PROTEIN |
8 | 0.0000081376 | TYPES OF ONTOGENY//RODENT POPULATIONS//CHROMATIN PHENOTYPE |
9 | 0.0000079044 | RYBINSK RESERVOIR//OC PESTICIDES//LEUCOGRAM |
10 | 0.0000078792 | LIPOSOMAL VALINOMYCIN//AGR LIFE SCI BACTERIOL//TETANUS TOXOID ANTIGEN |